News By Tag
* Drug Discovery
* More Tags...
News By Place
tebu-bio’s SilenciX cell lines presented at STS Meeting 2008 - Weimar
Dr. Ali el Bayâ (Sales Manager - tebu-bio Germany) will be presenting SilenciX at the forthcoming 12th STS Meeting 2008: Signal Transduction – Receptors, Mediators and Genes, in Weimar (DE) from October 29th to 31st 2008.
By: Sara Pierre, tebu-bio
Guarantee of target-specific knock-down at RNA level is at least 70%, cell lines produced so far mostly show over 85% silencing. Design of shRNAs is powered by the new DSIR algorithm for the prediction of RNAi efficacy and off-target blast screening.
The SilenciX technology allows long-term studies, consistent large cell supplies and high reproducibility in experiments, with no additional stress related to cell transfections, making it a reliable tool for target validation and drug discoveries in Life Sciences.
Dr Ali el Bayâ of tebu-bio (co-sponsors of the meeting) will be presenting SilenciX on Wednesday October 29th.
Further information and recent publications mentioning the SilenciX cell lines can be found at http://www.tebu-
# # #
tebu-bio is an expert in the supply and distribution of reagents for Life Sciences research in Europe and has its own R&D laboratories which provides contract services. Our tebu-bio.com catalogue provides access to the most innovative range of products.